Want to join the conversation?
$HOLX's domestic Breast Health business grew 11.2% in 2Q16 due to continued adoption of the Genius 3D mammography. International Breast Health revenue declined by low-single digits in constant currency, as 2Q15 results benefitted from sales of products that were since discontinued. Global Surgical sales grew 15.9% in constant currency in 2Q16.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.